Dr. Andrew M Evens DO, MS
Hematologist-Oncologist | Hematology & Oncology
55 Lake Ave N Acc Building Worcester MA, 01655About
Following graduation with honors from the Chicago College of Osteopathic Medicine at Midwestern University, Dr. Evens completed his Internal Medicine residency at Lutheran General Hospital and he serv ...
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Burkitt's and Burkitt-like lymphoma.
- TTP/HUS occurring in a simultaneous pancreas/kidney transplant recipient after clopidogrel treatment: evidence of a nonimmunological etiology.
- Radioimmunotherapy in non-Hodgkin's lymphoma: trials of yttrium 90-labeled ibritumomab tiuxetan and beyond.
- Motexafin gadolinium: a redox-active tumor selective agent for the treatment of cancer.
- Clinical characteristics of erythropoietin-associated pure red cell aplasia.
- Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group.
- The Research on Adverse Drug Events and Reports (RADAR) project.
- Motexafin gadolinium induces oxidative stress and apoptosis in hematologic malignancies.
- Oxidative stress and apoptosis: a new treatment paradigm in cancer.
- Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation.
- Targeting angiogenesis for the treatment of sarcoma.
- Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?
- G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis.
- Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
- Relapsed and refractory Hodgkin lymphoma: transplantation strategies and novel therapeutic options.
Clinical Trials
Awards
- Division of Hematology/Oncology, Northwestern University 2008-2009 Teaching Attending of the Year
- Department of Medicine, Northwestern University 2008 Annual Excellence in Teaching Award
- The Woman's Board of Northwestern Memorial Hospital 2005 Compassionate Care Annual Award
- 2002 Translational Research Award (most outstanding research presentation)
- 1998 First Place, Clinical Vignette for ACP Illinois Chapter Regional Meet
- 1996 Intern of the Year (class size: 35), Internal Medicine, Lutheran Gene
- 1994 Sigma Sigma Phi, National Osteopathic Honor Society, Downers Grove, I
- 1991 Magna Cum Laude, Biochemistry, Saint Joseph's College, Rensselaer, IN
- 1989 Bill Bradley Academic All-American, NCAA College Basketball
Treatments
- Non-hodgkin's Lymphoma, Hodgkin's Lymphoma, Stem Cell Transplant And More
Fellowships
- Northwestern University McGaw Medical Center, Fellow:Hematology/Oncology 2000
Dr. Andrew M Evens DO, MS's Practice location
Dr. Andrew M Evens DO, MS's reviews
Write ReviewRecommended Articles
- Black Sabbath's Tony Iommi Discusses Struggles with Lymphoma
Tony Iommi is one of the few rock and roll legends who can say that they fulfilled the industry’s cliché act of getting the band back together. In 2011, the loss of a good friend brought the Black Sabbath guitarist Iommi back into contact with the band’s original lead vocalist, Ozzy Osbourne....
- New Diagnostic Tool Approved for Lymphoma
A new diagnostic tool has been approved by the U.S. Food and Drug Administration (FDA) to help researchers identify leukemia and lymphoma cells by using a technique known as flow cytometry. A flow cytometry test for non-Hodgkin’s lymphoma (NHL) can help determine whether normal or abnormal DNA is...
- Lymphoma News: Mother Gives Birth to Healthy Daughter after Chemo During Pregnancy
Chemotherapy has a reputation for its not-so-great side effects. As many people know, chemotherapy is known to cause off target symptoms for most cancer patients such as nausea and vomiting, hair loss, and extreme fatigue. In addition to the symptoms that one may experience during treatment, some of...
- This New Zealand Native Beat Cancer Eight Times
Being diagnosed with cancer can be a world-shaking experience. Going through the necessary chemotherapy and radiation treatment to beat cancer can be a difficult struggle, but coming out cancer-free feels incredibly liberating.Maybe it’s that feeling of having beaten cancer that can make suffering...
- Overcoming Lymphoma: A South Philly Student's Story
In April of 2018, 18-year-old Alexis Carine was diagnosed with Hodgkin’s lymphoma (HL), a blood cancer that begins in the lymphatic system. Her diagnosis was stage II HL, a cancer found in two or more lymph node areas, and both are either above or below the diaphragm (the muscle located just...
- Morphos Declared a "Breakthrough Therapy" for Lymphoma
MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
Nearby Providers
- Dr. David Shepro M.D.299 Lincoln St Worcester MA 01605
- Dr. Humberto A Rossi M.D.20 PROSPECT ST MILFORD MA 01757
- Dr. Ahmad Daniyal Siddiqui MD55 Lake Avenue North Worcester MA 01655
- Dr. Amanpreet Buttar MD123 Summer St Worcester MA 01608
- Dr. Neil J. Kluger MD55 Lake Avenue North Worcester MA 01655
- Dr. Kathryn Edmiston M.D.55 LAKE AVE N WORCESTER MA 01655